(Q53570871)

15 May 2018

title

Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. (English)

1 reference

15 May 2018

1 reference

mesenchymal stem cell

1 reference

5

Marcin Majka

1 reference

15 May 2018

Olga Milczarek

2

object named as

Olga Milczarek

1 reference

15 May 2018

Anna Wędrychowicz

3

object named as

Anna Wedrychowicz

1 reference

15 May 2018

author name string

Danuta Jarocha

1

1 reference

15 May 2018

Stanislaw Kwiatkowski

4

1 reference

15 May 2018

publication date

24 March 2015

1 reference

15 May 2018

published in

Cell Transplantation

1 reference

15 May 2018

volume

24

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

661-672

1 reference

15 May 2018

Immunosuppressive properties of mesenchymal stem cells

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Functional recovery measures for spinal cord injury: an evidence-based review for clinical practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

An attempt to treat patients who have injured spinal cords with intralesional implantation of concentrated autologous bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Chondroitinase ABC promotes functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Epidemiology of traumatic spinal cord injury: trends and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Neural stem cell engraftment and myelination in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

IGF-I gene delivery promotes corticospinal neuronal survival but not regeneration after adult CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Biomarkers in psychiatry: drawbacks and potential for misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Remyelination of the spinal cord following intravenous delivery of bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Spinal axon regeneration induced by elevation of cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Spasticity following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Therapeutic interventions after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Evaluation of viable β-cell mass is useful for selecting collagenase for human islet isolation: comparison of collagenase NB1 and liberase HI

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687796

21 January 2018

Identifiers

DOI

10.3727/096368915X687796

1 reference

15 May 2018

1 reference

15 May 2018